How big is the Pharmacogenomics Market?

The Pharmacogenomics Market size is expected to reach USD 8.67 billion in 2024 and grow at a CAGR of 6.12% to reach USD 11.67 billion by 2029. Read More

What is the current Pharmacogenomics Market size?

In 2024, the Pharmacogenomics Market size is expected to reach USD 8.67 billion. Read More

Who are the key players in Pharmacogenomics Market?

Thermo Fisher Scientific Inc., Abbott Laboratories Inc., F. Hoffmann-La Roche AG, Bio-Rad Laboratories and Biomerieux SA are the major companies operating in the Pharmacogenomics Market. Read More

Which is the fastest growing region in Pharmacogenomics Market?

Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029). Read More

Which region has the biggest share in Pharmacogenomics Market?

In 2024, the North America accounts for the largest market share in Pharmacogenomics Market. Read More

What years does this Pharmacogenomics Market cover, and what was the market size in 2023?

In 2023, the Pharmacogenomics Market size was estimated at USD 8.14 billion. The report covers the Pharmacogenomics Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Pharmacogenomics Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

Pharmacogenomics Market Share

Statistics for the 2023 & 2024 Pharmacogenomics market share, created by Mordor Intelligence™ Industry Reports. Pharmacogenomics share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Market Share of Pharmacogenomics Industry

The pharmacogenomics market is highly fragmented due to several key players. The large interest of researchers and investment in the safety and efficiency of drugs by companies are the major factors responsible for the market's growth, making it highly competitive with the presence of many key players in the pharmacogenomics market. The government is also involved in funding companies that work to develop bioinformatics technology for precision medicine research applications. Some players are Abbott Laboratories Inc., Biomerieux SA, Becton, Dickinson and Company, Bio-Rad Laboratories Inc., Thermo Fisher Scientific, and F. Hoffman-La Roche Ltd.